Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Emergence Agitation in Nasal Surgery
NCT05634148Phase 3Completed
- Sponsor
- Security Forces Hospital
- Start
- Dec 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in Emergence agitation (EA), sponsored by Security Forces Hospital. Started Dec 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT05634148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05634148.